Giovannetti E - Search Results

1

Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function.

Van Der Steen N, Keller K, Dekker H, Porcelli L, Honeywell RJ, Van Meerloo J, Musters RJP, Kathmann I, Frampton AE, Liu DSK, Ruijtenbeek R, Rolfo C, Pauwels P, Giovannetti E, Peters GJ. Van Der Steen N, et al. Among authors: giovannetti e. J Cell Physiol. 2020 Nov;235(11):8085-8097. doi: 10.1002/jcp.29463. Epub 2020 Jan 20. J Cell Physiol. 2020. PMID: 31960422 Free PMC article.

2

Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels.

Giovannetti E, Backus HH, Wouters D, Ferreira CG, van Houten VM, Brakenhoff RH, Poupon MF, Azzarello A, Pinedo HM, Peters GJ. Giovannetti E, et al. Br J Cancer. 2007 Mar 12;96(5):769-75. doi: 10.1038/sj.bjc.6603639. Br J Cancer. 2007. PMID: 17339891 Free PMC article.

3

Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.

Giovannetti E, Ugrasena DG, Supriyadi E, Vroling L, Azzarello A, de Lange D, Peters GJ, Veerman AJ, Cloos J. Giovannetti E, et al. Leuk Res. 2008 Jan;32(1):19-24. doi: 10.1016/j.leukres.2007.02.011. Epub 2007 Mar 28. Leuk Res. 2008. PMID: 17395259

4

Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.

Giovannetti E, Lemos C, Tekle C, Smid K, Nannizzi S, Rodriguez JA, Ricciardi S, Danesi R, Giaccone G, Peters GJ. Giovannetti E, et al. Mol Pharmacol. 2008 Apr;73(4):1290-300. doi: 10.1124/mol.107.042382. Epub 2008 Jan 10. Mol Pharmacol. 2008. PMID: 18187583

5

Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.

Giovannetti E, Laan AC, Vasile E, Tibaldi C, Nannizzi S, Ricciardi S, Falcone A, Danesi R, Peters GJ. Giovannetti E, et al. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):720-5. doi: 10.1080/15257770802145447. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600531

6

Functional inactivity and mutations of p53 differentially affect sensitivity to 5-fluorouracil and antifolate inhibitors of thymidylate synthase (TS) by altering TS levels in colorectal cancer cells.

Giovannetti E, Backus HH, Wouters D, Peters GJ. Giovannetti E, et al. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):740-5. doi: 10.1080/15257770802145512. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600534

7

Immunocytochemical detection of hENT1 and hCNT1 in normal tissues, lung cancer cell lines, and NSCLC patient samples.

Hubeek I, Giovannetti E, Broekhuizen AJ, Pastor-Anglada M, Kaspers GJ, Peters GJ. Hubeek I, et al. Among authors: giovannetti e. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):787-93. doi: 10.1080/15257770802145942. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600541

8

Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells.

Lemos C, Kathmann I, Giovannetti E, Dekker H, Scheffer GL, Calhau C, Jansen G, Peters GJ. Lemos C, et al. Among authors: giovannetti e. Int J Cancer. 2008 Oct 1;123(7):1712-20. doi: 10.1002/ijc.23677. Int J Cancer. 2008. PMID: 18623116 Free article.

9

Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells.

Tekle C, Giovannetti E, Sigmond J, Graff JR, Smid K, Peters GJ. Tekle C, et al. Among authors: giovannetti e. Br J Cancer. 2008 Sep 2;99(5):750-9. doi: 10.1038/sj.bjc.6604566. Epub 2008 Aug 19. Br J Cancer. 2008. PMID: 18728666 Free PMC article.

10

Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins.

Lemos C, Kathmann I, Giovannetti E, Beliën JA, Scheffer GL, Calhau C, Jansen G, Peters GJ. Lemos C, et al. Among authors: giovannetti e. Mol Cancer Ther. 2009 Mar;8(3):655-64. doi: 10.1158/1535-7163.MCT-08-0768. Epub 2009 Feb 24. Mol Cancer Ther. 2009. PMID: 19240161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

401 results

Search Page